Xylem (XYL)
(Real Time Quote from BATS)
$131.75 USD
+1.14 (0.87%)
Updated Apr 26, 2024 12:03 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Income Statements
Fiscal Year end for Xylem Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 7,364 | 5,522 | 5,195 | 4,876 | 5,249 |
Cost Of Goods | 4,647 | 3,438 | 3,220 | 3,046 | 3,203 |
Gross Profit | 2,717 | 2,084 | 1,975 | 1,830 | 2,046 |
Selling & Adminstrative & Depr. & Amort Expenses | 2,065 | 1,462 | 1,390 | 1,463 | 1,560 |
Income After Depreciation & Amortization | 652 | 622 | 585 | 367 | 486 |
Non-Operating Income | 32 | -132 | 2 | -5 | -3 |
Interest Expense | 49 | 50 | 76 | 77 | 67 |
Pretax Income | 635 | 440 | 511 | 285 | 416 |
Income Taxes | 26 | 85 | 84 | 31 | 15 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 609 | 355 | 427 | 254 | 401 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 609 | 355 | 427 | 254 | 401 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,088 | 858 | 830 | 676 | 891 |
Depreciation & Amortization (Cash Flow) | 436 | 236 | 245 | 309 | 405 |
Income After Depreciation & Amortization | 652 | 622 | 585 | 367 | 486 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 218.20 | 181.00 | 181.50 | 181.10 | 181.20 |
Diluted EPS Before Non-Recurring Items | 3.78 | 2.85 | 2.49 | 2.06 | 3.02 |
Diluted Net EPS (GAAP) | 2.79 | 1.96 | 2.35 | 1.40 | 2.21 |
Fiscal Year end for Xylem Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 2,118.00 | 2,076.00 | 1,722.00 | 1,448.00 |
Cost Of Goods | NA | 1,362.00 | 1,312.00 | 1,071.00 | 902.00 |
Gross Profit | NA | 756.00 | 764.00 | 651.00 | 546.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 545.00 | 573.00 | 532.00 | 415.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 211.00 | 191.00 | 119.00 | 131.00 |
Non-Operating Income | NA | 14.00 | 8.00 | 7.00 | 4.00 |
Interest Expense | NA | 14.00 | 14.00 | 12.00 | 9.00 |
Pretax Income | NA | 210.00 | 185.00 | 114.00 | 126.00 |
Income Taxes | NA | -56.00 | 33.00 | 22.00 | 27.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 266.00 | 152.00 | 92.00 | 99.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 266.00 | 152.00 | 92.00 | 99.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 242.50 | 242.20 | 206.70 | 181.30 |
Diluted EPS Before Non-Recurring Items | NA | 0.99 | 0.99 | 0.98 | 0.72 |
Diluted Net EPS (GAAP) | NA | 1.17 | 0.63 | 0.45 | 0.54 |